Evidence map›Paper›PMID 34221206›Full record

ArticlePharmacy practice

An ounce of prevention is worth a pound of cure: considerations for pharmacists delivering the National Diabetes Prevention Program.

Dave L Dixon, Evan M Sisson, Lauren G Pamulapati, Rowan Spence, Teresa M Salgado

Abstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dave L DixonPharmD. Center for Pharmacy Practice Innovation, School of Pharmacy, Virginia Commonwealth University, Richmond, VA (United States). DLDixon@vcu.edu.ORCID https://orcid.org/0000-0001-7560-9521
Evan M SissonPharmD, MSHA. Center for Pharmacy Practice Innovation, School of Pharmacy, Virginia Commonwealth University, Richmond, VA (United States). emsisson@vcu.edu.ORCID https://orcid.org/0000-0003-3961-853X
Lauren G PamulapatiPharmD. Center for Pharmacy Practice Innovation, School of Pharmacy, Virginia Commonwealth University, Richmond, VA (United States). lgpamulapati@vcu.edu.ORCID https://orcid.org/0000-0002-8371-0870
Rowan SpenceBS. School of Pharmacy, Virginia Commonwealth University, Richmond, VA (United States). rspence@mymail.vcu.edu.ORCID https://orcid.org/0000-0002-7832-115X
Teresa M SalgadoMPharm, PhD. Center for Pharmacy Practice Innovation, School of Pharmacy, Virginia Commonwealth University, Richmond, VA (United States). tmsalgado@vcu.edu.ORCID https://orcid.org/0000-0003-2708-7145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediabetes is highly prevalent in the United States affecting over 88 million adults. In 2010, the Centers for Disease Control and Prevention (CDC) established the National Diabetes Prevention Program (NDPP), an intensive lifestyle program consisting of a 16-lesson curriculum focused on diet, exercise, and behavior modification, with the ultimate goal to reduce progression from prediabetes to diabetes. Despite tens of millions of adults potentially qualifying to participate in the program, the uptake of the NDPP has been exceedingly low. As a result, the CDC has focused its efforts on engaging with local health departments and community partners, including community pharmacies, across the United States to scale-up enrollment in the NDPP. In this commentary we discuss factors affecting implementation of the NDPP in community pharmacies and other settings where pharmacists practice, including training, space, personnel, recruitment and enrollment, retention, and sustainability.

Indexed as

Behavior TherapyCenters for Disease Control and PreventionDiabetes MellitusDietExerciseHealth Plan ImplementationHealth PromotionLife StylePharmaciesPharmacistsPrediabetic StateType 2United StatesU.S.

Identifiers

PMID34221206
PMCPMC8221748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.